Total Credits: 1 including 1 AMA PRA Category 1 Credit(s)™, 1 AOA Category 1-A Credit(s)
** Please note this program was a part of the VOC 2023. You will not want to choose this program if you completed this individual program as part of the VOC 2023. **
1) Learners will develop a pharmacologic rationale and understanding of the effects that THC and other psychoactive substances have on behavior, brain, and personality development in adolescents and adults.
2) Learners will apply the information from this presentation to educate their patients on the potential adverse and undesired effects of using legally obtained THC psychoactive substances.
3) Learners will provide validated and informed counseling to their patients and/or family members, empowering them to make reasonable and informed decisions regarding the use of these increasingly accessible and affordable substances.
4) Learners will be able to confidently engage their patients in informed discussions of the risks and benefits of using psychoactive substances like THC to address physical and psychological issues.
Accreditation Statement: Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 1 AOA Category 1-A CME credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation.
The Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Planning Disclosure: The Missouri Association of Osteopathic Physicians and Surgeons Education Planning Committee has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients relative to the content of this presentation.
Grievance Policy: All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt. If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Bureau of Osteopathic Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.
|Handout - F6B) Dr. Marcus Iszard - Emerging Evidence for Marijuana-Induced Psychosis (1.45 MB)||38 Pages||Available after Purchase|
Dr. Marcus Iszard is an Associate Professor of Pharmacology at Kansas City University, College of Osteopathic Medicine in Kansas City and Joplin, Missouri. He also is a Consultant and a Licensed Private Drug Investigator. He provides consulting and investigation services for law enforcement agencies and private/corporate law firms for criminal or civil legal matters. Dr. Iszard received his Doctor of Philosophy (Pharmacology/Toxicology) from Florida A&M University in Tallahassee, Florida. He completed his fellowship at the University of Kansas School of Medicine, Department of Pharmacology, Toxicology, and Therapeutics in Kansas City, Kansas.
Dr. Iszard was awarded the Lawrence Ferring Faculty Award as Teacher of the Year in 2004 at Xavier University of Louisiana, College of Pharmacy, in New Orleans, Louisiana. He is also a member of the Rho Chi Pharmacy National Honor Society.
Dr. Iszard is married and has two children. He enjoys Ham Radio in his spare time.
Dr. Iszard discloses that he has no relevant financial relationships with any organization producing, marketing, reselling, or distributing healthcare goods or services consumed by, or used on, patients relative to the content of this presentation.